No abstract available
MeSH terms
-
Antineoplastic Agents / economics
-
Antineoplastic Agents / therapeutic use*
-
Cost-Benefit Analysis
-
Health Care Rationing* / economics
-
Humans
-
Lenalidomide
-
Multiple Myeloma / drug therapy*
-
Quality-Adjusted Life Years
-
Recurrence
-
Technology Assessment, Biomedical* / economics
-
Thalidomide / analogs & derivatives*
-
Thalidomide / economics
-
Thalidomide / therapeutic use
-
United Kingdom
Substances
-
Antineoplastic Agents
-
Thalidomide
-
Lenalidomide